Jeong‐A Lim

2.1k total citations · 1 hit paper
23 papers, 1.6k citations indexed

About

Jeong‐A Lim is a scholar working on Rheumatology, Physiology and Genetics. According to data from OpenAlex, Jeong‐A Lim has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 14 papers in Physiology and 9 papers in Genetics. Recurrent topics in Jeong‐A Lim's work include Glycogen Storage Diseases and Myoclonus (14 papers), Lysosomal Storage Disorders Research (13 papers) and Autophagy in Disease and Therapy (6 papers). Jeong‐A Lim is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (14 papers), Lysosomal Storage Disorders Research (13 papers) and Autophagy in Disease and Therapy (6 papers). Jeong‐A Lim collaborates with scholars based in United States, Italy and Israel. Jeong‐A Lim's co-authors include Nina Raben, Lishu Li, Rosa Puertollano, José A. Martina, Heba I. Diab, Simona Patange, Hossein Zare, Baodong Sun, Andrea Ballabio and Priya S. Kishnani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Molecular Therapy.

In The Last Decade

Jeong‐A Lim

22 papers receiving 1.6k citations

Hit Papers

The Nutrient-Responsive Transcription Factor TFE3 Promote... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeong‐A Lim United States 13 711 650 647 324 305 23 1.6k
Lishu Li United States 6 552 0.8× 482 0.7× 446 0.7× 254 0.8× 242 0.8× 8 1.1k
Edoardo Nusco Italy 22 519 0.7× 532 0.8× 720 1.1× 168 0.5× 319 1.0× 37 1.5k
Shoichi Takikita United States 16 408 0.6× 556 0.9× 461 0.7× 117 0.4× 153 0.5× 25 1.1k
Anna Chiara Nascimbeni Italy 22 649 0.9× 304 0.5× 842 1.3× 133 0.4× 459 1.5× 32 1.6k
Fabio Annunziata Italy 8 615 0.9× 467 0.7× 500 0.8× 414 1.3× 410 1.3× 9 1.3k
Agnieszka Ługowska Poland 20 332 0.5× 714 1.1× 428 0.7× 85 0.3× 211 0.7× 70 1.1k
Gouri Yogalingam Australia 20 393 0.6× 617 0.9× 448 0.7× 85 0.3× 266 0.9× 33 1.2k
Outi Kopra Finland 29 147 0.2× 845 1.3× 1.0k 1.5× 187 0.6× 622 2.0× 35 2.0k
Jakub Sikora Czechia 20 182 0.3× 487 0.7× 507 0.8× 137 0.4× 186 0.6× 48 1.1k
Amparo Chabás Spain 26 435 0.6× 1.4k 2.2× 727 1.1× 82 0.3× 690 2.3× 90 1.8k

Countries citing papers authored by Jeong‐A Lim

Since Specialization
Citations

This map shows the geographic impact of Jeong‐A Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong‐A Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong‐A Lim more than expected).

Fields of papers citing papers by Jeong‐A Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeong‐A Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong‐A Lim. The network helps show where Jeong‐A Lim may publish in the future.

Co-authorship network of co-authors of Jeong‐A Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Jeong‐A Lim. A scholar is included among the top collaborators of Jeong‐A Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeong‐A Lim. Jeong‐A Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jeck, William R., Deeksha Bali, Sarah Young, et al.. (2024). Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX γ2 models human disease. Molecular Genetics and Metabolism. 143(4). 108597–108597.
3.
Choi, Su Jin, John S. Yi, Jeong‐A Lim, et al.. (2023). Successful AAV8 readministration: Suppression of capsid‐specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease. The Journal of Gene Medicine. 25(8). e3509–e3509. 11 indexed citations
4.
Koeberl, Dwight D., et al.. (2023). Gene therapy for glycogen storage diseases. Journal of Inherited Metabolic Disease. 47(1). 93–118. 14 indexed citations
5.
Lim, Jeong‐A, Priya S. Kishnani, & Baodong Sun. (2022). Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice. JCI Insight. 7(23). 7 indexed citations
6.
Lim, Jeong‐A, Su Jin Choi, Lani Clinton, et al.. (2021). Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2/ mouse model. Molecular Genetics and Metabolism. 133(3). 269–276. 5 indexed citations
7.
Lim, Jeong‐A, Su Jin Choi, Fengqin Gao, Priya S. Kishnani, & Baodong Sun. (2020). A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme. Molecular Therapy — Methods & Clinical Development. 18. 240–249. 18 indexed citations
8.
Lim, Jeong‐A, et al.. (2019). An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond. Annals of Translational Medicine. 7(13). 289–289. 49 indexed citations
9.
Lim, Jeong‐A, Naresh Kumar Meena, & Nina Raben. (2019). Pros and cons of different ways to address dysfunctional autophagy in Pompe disease. Annals of Translational Medicine. 7(13). 279–279. 11 indexed citations
10.
Lim, Jeong‐A, Baodong Sun, Rosa Puertollano, & Nina Raben. (2018). Therapeutic Benefit of Autophagy Modulation in Pompe Disease. Molecular Therapy. 26(7). 1783–1796. 41 indexed citations
11.
Choi, Eun Kyung, Jeong‐A Lim, Jong-Kwang Kim, et al.. (2018). Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors. Experimental & Molecular Medicine. 50(10). 1–16. 9 indexed citations
12.
Lim, Jeong‐A, Hossein Zare, Rosa Puertollano, & Nina Raben. (2017). Atg5flox-Derived Autophagy-Deficient Model of Pompe Disease: Does It Tell the Whole Story?. Molecular Therapy — Methods & Clinical Development. 7. 11–14. 11 indexed citations
13.
Lim, Jeong‐A, Lishu Li, Orian S. Shirihai, et al.. (2017). Modulation of mTOR signaling as a strategy for the treatment of Pompe disease. EMBO Molecular Medicine. 9(3). 353–370. 74 indexed citations
14.
Lim, Jeong‐A, et al.. (2016). α-Syntrophin is involved in the survival signaling pathway in myoblasts under menadione-induced oxidative stress. Experimental Cell Research. 344(1). 1–10. 7 indexed citations
15.
Lim, Jeong‐A, Lishu Li, Or Kakhlon, Rachel Myerowitz, & Nina Raben. (2015). Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy. 11(2). 385–402. 100 indexed citations
16.
Lim, Jeong‐A, Or Kakhlon, Lishu Li, Rachel Myerowitz, & Nina Raben. (2015). Pompe disease: Shared and unshared features of lysosomal storage disorders. PubMed. 3(1). e1068978–e1068978. 29 indexed citations
17.
Lim, Jeong‐A, Lishu Li, & Nina Raben. (2014). Pompe disease: from pathophysiology to therapy and back again. Frontiers in Aging Neuroscience. 6. 177–177. 148 indexed citations
18.
Martina, José A., Heba I. Diab, Lishu Li, et al.. (2014). The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris. Science Signaling. 7(309). ra9–ra9. 503 indexed citations breakdown →
19.
Spampanato, Carmine, Erin Feeney, Lishu Li, et al.. (2013). Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Molecular Medicine. 5(5). 691–706. 262 indexed citations
20.
Lim, Jeong‐A, et al.. (2006). A Study on Genetic Analysis and Extract Cytotoxicity of Scolopendra subspinipes multilans L. Koch. SHILAP Revista de lepidopterología. 9(2). 49–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026